UChicago Medicine Comprehensive Cancer Center

Low-Grade vs. High-Grade Ovarian Cancer

Low-grade cancers tend to grow more slowly, while high-grade cancers grow more quickly and are more likely to spread. Epithelial ovarian cancers occur in the tissues that line the outer surfaces of the ovaries. Low-grade ovarian cancer subtypes make up about 10% of all epithelial ovarian cancer cases. 
 

Symptoms

The symptoms of low-grade ovarian cancer are often vague, and include the following:

  • Bloating
  • Abdominal or pelvic pain
  • Changes in bowel movements
  • Feeling full quickly when eating 

These symptoms are the same as other ovarian cancers, including high-grade serous ovarian cancer. 

Diagnosis

Unlike high-grade cancers, low-grade ovarian cancers do not respond well to conventional chemotherapy and may respond better to aggressive surgery and endocrine (hormone) therapy, and possibly other targeted therapies. 

As a result, the correct diagnosis is critical to creating the best treatment plan.  This distinction is made with a microscopic assessment of the cancer cells by a pathologist. At UChicago Medicine Comprehensive Cancer Center, our dedicated gynecologic pathologists are expertly trained and experienced in ensuring an accurate diagnosis, whether you choose to have your care at UChicago Medicine or if you come to us for a second opinion.

 

microscopic example of low-grade serous epithelial ovarian cancer
A microscopic example of low-grade serous cancer.

Initial Treatment for Low-Grade Epithelial Ovarian Cancer

Surgery is a critical component of the initial treatment for low-grade ovarian cancer. Our team of gynecologic cancer specialists will discuss in detail the extent of surgery that is needed based on your cancer. Whenever possible, we use minimally invasive (laparoscopic) surgical techniques that allow for smaller incisions. This approach typically results in a faster recovery, minimal scarring, and a reduced risk for post-surgical complications as compared to a traditional open surgical procedure. Tissue removed during surgery will be reviewed by our expert gynecologic pathologists to confirm an accurate diagnosis. Information from the pathologist’s report will guide an individualized follow-up plan that is tailored to your needs. 

For young patients of childbearing age, fertility-sparing surgery may be possible. We also collaborate closely with our reproductive endocrinology and infertility team to ensure all potential reproductive considerations are being addressed before surgery. Learn more about oncofertility.

In situations where cancer has spread more widely, our surgeons take a more aggressive approach to remove affected tissues. Our highly skilled team of gynecologic cancer surgeons has a track record of excellent surgical outcomes with high rates of removing all visible cancer—an important factor that significantly improves cancer-related outcomes. When needed, we also frequently partner with our surgical oncology colleagues to maximize the chances of completely removing cancer from areas that are more difficult to access. 

Treatment for Recurrent Low-Grade Ovarian Cancer

Unfortunately, for many women with low-grade ovarian cancer, recurrence will happen at some point. Depending upon where and how quickly the cancer returns, treatment for recurrent low-grade ovarian cancer may include surgery, systemic therapy—such as chemotherapy or hormone receptor-targeting agents—or a combination of surgery and other therapeutic options. We take the best, individualized approach based on your specific symptoms, imaging findings and previous treatments. In these situations, some treatments that target specific tumor mutations may be most appropriate for certain patients.

Newer Treatments for Low-Grade Cancers

Since conventional chemotherapy fails to work well in many low-grade cancers, newer, more effective treatments for this rare cancer type are urgently needed. We offer enrollment in various clinical trials, which give our patients access to promising new treatments that may be more successful at targeting low-grade ovarian cancers. These options are frequently changing as we open new trials and complete other trials. If you are interested in learning more about our clinical trials, please schedule an appointment or contact us for more details.

 

Convenient Locations for Gynecologic Oncology Care

Request an Appointment

We are currently experiencing a high volume of inquiries, leading to delayed response times. For faster assistance, please call 1-855-702-8222 to schedule your appointment.

If you have symptoms of an urgent nature, please call your doctor or go to the emergency room immediately.

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.

* Indicates required field

By submitting this form you acknowledge the risk of sending this information by email and agree not to hold the University of Chicago or University of Chicago Medical Center liable for any damages you may incur as a result of the transfer or use of this information. The use or transmittal of this form does not create a physician-contact relationship. More information regarding the confidentiality of this request can be found in our Privacy Policy.
S. Diane Yamada, MD, and Ernst Lengyel, MD, gynecologic oncologists

Cancer Care Second Opinions

Request a second opinion from UChicago Medicine experts in cancer care.

researcher in cancer lab

Participate in a Clinical Trial

UChicago Medicine ovarian cancer experts are actively conducting clinical trials of new and promising treatments.

Young black female patient talking with doctor or nurse

Gynecologic Cancer Prevention Clinic

Our cancer prevention experts provide comprehensive and personalized care for women at elevated risk for endometrial (uterine) cancer and ovarian cancer.